Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,194 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,194 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,194 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,194 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,194 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,194 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,194 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Max Reinhardt President, Global Spine
Sold at will
$13.95K 1,080 at 12.92
3.9%
Not planned
4 Mar 2026
Bret T Jardine Chief Legal Officer
Sold on a plan
$13.43K 1,090 at 12.32
13.5%
Planned (10b5-1)
4 Mar 2026
Reuven Spiegel Executive Vice President, DKL
Sold on a plan
$13.30K 250 at 53.20
1.1%
Planned (10b5-1)
4 Mar 2026
Paul Streck EVP, Head of R&D
Sold at will 2×
$11.71K 1,879 at 6.23
2.4%
Not planned
4 Mar 2026
Michael Anthony Steenberge Chief Accounting Officer
Sold on a plan
$10.63K 582 at 18.27
2.2%
Planned (10b5-1)
4 Mar 2026
Allison Swartz EVP, GC
Sold on a plan
$10.51K 599 at 17.54
0.7%
Planned (10b5-1)
4 Mar 2026
Nicholas Tatum Chief Accounting Officer
Sold on a plan 2×
$10.22K 893 at 11.45
1.5%
Planned (10b5-1)
4 Mar 2026
Patrick Fisher President, Global Limb Recon
Sold at will
$10.05K 778 at 12.92
1.5%
Not planned
4 Mar 2026
Martin Javier San Chief Medical Officer
Sold at will
$9.24K 1,720 at 5.37
9.8%
Not planned
4 Mar 2026
Andrew Cappotelli Sr Vice President Operations
Sold on a plan
$7.87K 70 at 112.48
0.4%
Planned (10b5-1)
4 Mar 2026
Walid Abi-Saab Chief Medical Officer
Sold at will
$7.32K 808 at 9.06
0.4%
Not planned
4 Mar 2026
Kevin Church Chief Scientific Officer
Sold at will
$7.30K 1,359 at 5.37
5.1%
Not planned
4 Mar 2026
Mark Worthington GENERAL COUNSEL and CCO
Sold at will
$7.13K 1,328 at 5.37
6.7%
Not planned
4 Mar 2026
Ali Sadri Chief Technology Officer
Sold on a plan
$5.11K 1,228 at 4.16
1.0%
Planned (10b5-1)
4 Mar 2026
Eric Rosenfeld Chief SPAC Officer
Sold at will
$4.32K 1,440,000 at 0.00
51.6%
Sold half or more
4 Mar 2026
Mark Hopman Chief Commercial Officer
Sold on a plan
$4.08K 353 at 11.57
0.3%
Planned (10b5-1)
4 Mar 2026
Edmund Dunn Principal Accounting Officer
Sold at will
$2.50K 139 at 17.96
0.6%
Not planned
4 Mar 2026
Matthew Tappin President, Software Products
Sold at will
$1.85K 185 at 10.00
7.1%
Not planned
4 Mar 2026
William Andrew Macan EVP, CLO and CS
Sold at will
$816.06 609 at 1.34
0.1%
Not planned
3 Mar 2026
Heather L. Hasson Executive Chair
Sold at will
$9.38M 556,327 at 16.85
30.8%
Not planned
3 Mar 2026
Dean C Athanasia Co-President
Sold at will
$6.86M 136,558 at 50.21
19.6%
Not planned
3 Mar 2026
C Frank Bennett EVP, Chief Scientific Officer
Sold on a plan 3×
$6.74M 85,089 at 79.23
51.4%
Sold half or more
3 Mar 2026
Priya Aiyar Chief Legal Officer
Sold at will
$6.31M 223,512 at 28.24
19.6%
Not planned
3 Mar 2026
Kris Rasmussen Chief Technology Officer
Sold on a plan 3×
$5.34M 179,331 at 29.80
1.7%
Planned (10b5-1)
3 Mar 2026
Steven Baert Chief People Officer
Sold at will
$4.51M 5,300 at 850.00
29.5%
Not planned
3 Mar 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 3×
$4.48M 25,641 at 174.61
42.6%
Planned (10b5-1)
3 Mar 2026
Hossein Razzaghi Chief Commercial Officer
Sold on a plan
$4.31M 43,119 at 100.00
5.7%
Planned (10b5-1)
3 Mar 2026
Richard Daniell EVP, Europe Commercial
Sold on a plan 2×
$4.17M 128,985 at 32.36
72.7%
Sold half or more
3 Mar 2026
Adam Blitzer Chief Operating Officer
Sold on a plan 9×
$3.54M 32,092 at 110.24
12.2%
Planned (10b5-1)
3 Mar 2026
Brian J. Wenzel Sr. See remarks
Sold on a plan
$3.16M 47,112 at 67.16
42.3%
Planned (10b5-1)
3 Mar 2026
Julie Shaeff Chief Accounting Officer
Sold at will
$3.16M 2,287 at 1,382.15
14.3%
Not planned
3 Mar 2026
Pedro J. Lopez-Baldrich Chief Legal Officer
Sold on a plan 4×
$2.78M 24,099 at 115.16
91.4%
Sold half or more
3 Mar 2026
Eric A Hughes See "Remarks"
Sold on a plan 2×
$2.61M 80,762 at 32.36
86.3%
Sold half or more
3 Mar 2026
Joseph F Wayland Executive Vice President and*
Sold at will
$2.57M 7,645 at 336.44
12.0%
Not planned
3 Mar 2026
Myriam Curet EVP & Chief Medical Officer · indirect
Sold on a plan
$2.30M 4,728 at 487.18
92.0%
Sold half or more
3 Mar 2026
Bruno Pietracci President, Latin America OU
Sold at will
$2.28M 28,765 at 79.41
100%
Sold half or more
3 Mar 2026
Amy Rochelle Davis VP & Pres. - Accelera and Com
Sold on a plan 6×
$2.28M 4,054 at 561.34
20.4%
Planned (10b5-1)
3 Mar 2026
Peter T Heilmann EVP, Chief Admin. Officer & GC
Sold at will
$2.15M 13,000 at 165.46
28.5%
Not planned
3 Mar 2026
Amy Girdwood Chief People & Culture Officer
Sold at will
$2.12M 75,030 at 28.25
6.8%
Not planned
3 Mar 2026
Scott Dreyer EVP & Chief Commercial Officer
Sold on a plan 2×
$2.02M 49,976 at 40.41
41.0%
Planned (10b5-1)
3 Mar 2026
Nancy Quan Executive Vice President
Sold at will
$1.87M 23,556 at 79.50
9.5%
Not planned
3 Mar 2026
Shannon L. Devers EVP, Chief Human Resources Ofc
Sold on a plan 3×
$1.60M 20,106 at 79.40
47.1%
Planned (10b5-1)
3 Mar 2026
Terrence Reed SVP & CHRO
Sold at will
$1.56M 1,116 at 1,397.33
28.3%
Not planned
3 Mar 2026
Jonathan M. Craig MD, Head of Investor Services · indirect
Sold on a plan 2×
$1.37M 14,481 at 94.60
100%
Sold half or more
3 Mar 2026
Frank Keller EVP, GM, Large Ent & Mer Plat.
Sold on a plan 3×
$1.36M 29,581 at 46.02
36.5%
Planned (10b5-1)
3 Mar 2026
Nasym Afsari General Counsel and Secretary
Sold on a plan
$1.23M 43,348 at 28.37
17.5%
Planned (10b5-1)
3 Mar 2026
Lesley Evancho Chief Human Resources Officer
Sold at will
$1.21M 20,000 at 60.69
9.8%
Not planned
3 Mar 2026
Nimrata Hunt Executive Vice President
Sold at will
$1.12M 1,758 at 634.57
8.8%
Not planned
3 Mar 2026
Jason Gray GC, Secretary & Admin Officer
Sold at will
$1.08M 73,174 at 14.74
26.0%
Not planned
3 Mar 2026
Raouf Abdel EVP, Global Operations
Sold at will
$1.07M 1,103 at 973.42
12.4%
Not planned
Showing 13,201–13,250 of 20,194. ← Newer Page 265 of 404 Older →